If you have time on your hands, have a look at the data for the CarT drugs given fast track FDA approval so far.
They have anywhere from a 40 to 75 percent response rate, but have adverse event rates as high as 79%. Some of the adverse events are life ending. So the results posted by CHM are excellent. Lets hope they remain that way.
CarT drugs have been approved for illness with no effective standard of care. The patients that recieve the drug have no other choice. Have a look at the FDA warning that are attached to their alreasy approved CarT drugs.
The way the first cohort were administered the drug is not representitve of how the final tteatment will happen, and it was at the lowest dose. To not be excited that even this produced stable disease in 75% of the arms is hard to believe.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)